Cargando…
Cell Replacement Therapy for Retinal and Optic Nerve Diseases: Cell Sources, Clinical Trials and Challenges
The aim of this review was to provide an update on the potential of cell therapies to restore or replace damaged and/or lost cells in retinal degenerative and optic nerve diseases, describing the available cell sources and the challenges involved in such treatments when these techniques are applied...
Autores principales: | Coco-Martin, Rosa M., Pastor-Idoate, Salvador, Pastor, Jose Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230855/ https://www.ncbi.nlm.nih.gov/pubmed/34208272 http://dx.doi.org/10.3390/pharmaceutics13060865 |
Ejemplares similares
-
Intravitreal allogeneic mesenchymal stem cells: a non-randomized phase II clinical trial for acute non-arteritic optic neuropathy
por: Pastor, Jose C., et al.
Publicado: (2023) -
Mesenchymal stem cell therapy in retinal and optic nerve diseases: An update of clinical trials
por: Labrador-Velandia, Sonia, et al.
Publicado: (2016) -
Short-Wavelength Light–Blocking Filters and Oral Melatonin Administration in Patients With Retinitis Pigmentosa: Protocol for a Randomized Controlled Trial
por: Pastor-Idoate, Salvador, et al.
Publicado: (2023) -
Matrix Metalloproteinases in Age-Related Macular Degeneration (AMD)
por: García-Onrubia, Luis, et al.
Publicado: (2020) -
Surgical Options for Optic Disc Pit Maculopathy: Perspectives and Controversies
por: Pastor-Idoate, Salvador, et al.
Publicado: (2020)